Nuzenio

Lantern Pharma Inc

Lantern Pharma Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 8 publisher sources 100/100 entity strength

Latest news

LTRN News | LANTERN PHARMA INC (NASDAQ:LTRN) - ChartMillChartMill · Sat, 08 Aug 2026 06:54:27 GMT Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET - Business WireBusiness Wire · Fri, 07 Aug 2026 12:00:00 GMT Lantern Pharma (LTRN): Empery Asset Management discloses 9.99% beneficial stake - Stock TitanStock Titan · Tue, 04 Aug 2026 14:04:24 GMT Lantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine - BioSpaceBioSpace · Tue, 04 Aug 2026 04:25:15 GMT Lantern Pharma (LTRN) Establishes Open-Medicine AI to Expand Mul - GuruFocusGuruFocus · Tue, 04 Aug 2026 03:00:00 GMT Lantern Pharma establishes Open-Medicine AI to commercialize multi-agent AI co-scientist platform - TradingViewTradingView · Mon, 03 Aug 2026 21:33:03 GMT Enterprise value to revenue forward of Lantern Pharma Inc. – NASDAQ:LTRN - TradingViewTradingView · Sat, 01 Aug 2026 10:34:27 GMT Lantern Pharma to Advance EMA-Cleared Phase 1b/2 Trial of LP-184 (Zirdafulven) in Biomarker-Selected Advanced Bladder Cancer - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 06:54:27 GMTLTRN News | LANTERN PHARMA INC (NASDAQ:LTRN) - ChartMill

Fri, 07 Aug 2026 12:00:00 GMTLantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET - Business Wire

Tue, 04 Aug 2026 14:04:24 GMTLantern Pharma (LTRN): Empery Asset Management discloses 9.99% beneficial stake - Stock Titan

Tue, 04 Aug 2026 04:25:15 GMTLantern Pharma (Nasdaq: LTRN) Establishes Open-Medicine AI as a Separate Company to Commercialize and Expand Its Multi-Agent AI Co-Scientist Platform for the Transformation of Medicine - BioSpace

Tue, 04 Aug 2026 03:00:00 GMTLantern Pharma (LTRN) Establishes Open-Medicine AI to Expand Mul - GuruFocus

Mon, 03 Aug 2026 21:33:03 GMTLantern Pharma establishes Open-Medicine AI to commercialize multi-agent AI co-scientist platform - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

LTRN10 live mentions Lantern Pharma6 live mentions Medicine AI6 live mentions NASDAQ4 live mentions Establishes Open4 live mentions Pharma3 live mentions Report Second Quarter2 live mentions Operating2 live mentions Financial Results2 live mentions August2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Lantern Pharma Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.